Filtering by: Opioid use disorders
Sep
16
12:00 PM12:00
Perinatal, Mental Health, Opioid use disorders, Quality improvement, Health Equity

CDIAS PSMG: Patricia Lee King

Foundations for improving perinatal mental health care through a statewide birthing hospital quality improvement collaborative

Patricia Lee King, PhD, MSW
Northwestern University

ABSTRACT:
Mental health conditions, including substance use disorders, are a leading cause of pregnancy-related deaths. One in five mothers experience depression or anxiety during pregnancy or postpartum and less than 10% receive adequate treatment. The Illinois Perinatal Quality Collaborative (ILPQC) facilitates collaborative learning opportunities, rapid-response data and quality improvement support to birthing hospitals through a collaborative infrastructure. In May 2025, the Illinois Perinatal Quality Collaborative (ILPQC) launched the Perinatal Mental Health Initiative with over 70 birthing hospitals. This initiative builds on previous statewide initiatives addressing Mothers and Newborns affected by Opioids (2018-2020) and Birth Equity (2021-2024) which demonstrated improvement in perinatal quality and patient outcomes. The aim of the ILPQC Perinatal Mental Health Initiative is to increase the percent of pregnant women with current perinatal mental health conditions who receive treatment and connection to resources during pregnancy, delivery and postpartum.

View Event →
Nov
18
12:00 PM12:00
MOUD, Mutual Help Groups, 12-Step Programs, Implementation Science, Health Services Research, User Centered Design, Opioid use disorders

CDIAS PSMG: Wayne Kepner

“Beyond the False Dichotomy” Bridging the MOUD-Mutual Help Group Divide

Wayne Kepner, PhD, MPH
Stanford University

ABSTRACT:
A significant barrier to addressing the opioid crisis is the "false dichotomy" between two of our most effective strategies; medications for opioid use disorder (MOUD) and 12-step mutual help groups (MHG). MOUD is the most effective pharmacological treatment to reduce mortality, while MHGs provide invaluable access to peer-based recovery capital. A fragmented system of care exists despite evidence that combining these approaches yields superior outcomes. Facilities offering recovery support services are nearly eight times more likely to exclude MOUD patients, forcing individuals to navigate seemingly incompatible systems where they may be discouraged from MOUD use, increasing risks of treatment discontinuation and overdose.

View Event →
Apr
22
12:00 PM12:00
Clinical Trial, Health disparities, Intimate Partner Violence, Opioid use disorders, Psychotherapy, Trauma

CDIAS PSMG: Tanya Saraiya

Addressing Underlying Trauma in Opioid Use

Tanya Saraiya, PhD
Medical University of South Carolina

ABSTRACT:
Up to 90% of people with opioid use disorder (OUD) have trauma exposure and up to 41% have posttraumatic stress disorder (PTSD). However, studies estimate that less than 12% of people with OUD and co-occurring PTSD receive treatment for their PTSD. Dr. Saraiya will present her early career work on assessing and addressing underlying trauma among people struggling with opioid use. Specifically, she will share findings from a new integrated therapy for opioid use disorder and PTSD and the development of a digital toolkit to assess for intimate partner violence in three opioid treatment programs in South Carolina. Throughout this talk, other projects and associated reflections on how systemic racism and healthcare barriers influence trauma and opioid use treatment will be discussed.

View Event →
Mar
25
12:00 PM12:00
Mobile Technology, Neonatal Abstinence Syndr, Opioid use disorders, Perinatal

CDIAS PSMG: Ekaterina Burduli

A Mobile Approach to Empower Perinatal Women with Opioid Use Disorder and Enhance Neonatal Abstinence Syndrome Care

Ekaterina Burduli, PhD, MS
Washington State University

ABSTRACT:
Substance use during pregnancy and parenthood presents significant public health challenges, with potentially severe consequences for mothers and infants with Neonatal Abstinence Syndrome (NAS). Addressing this issue requires innovative, comprehensive interventions and patient-centered approaches to improve care for perinatal women and families impacted by substance use disorders (SUD). This presentation will describe a NIDA-funded K01 study that focuses on developing and assessing the usability, acceptability, and feasibility of a mobile educational tool designed to support pregnant women with OUD in navigating the perinatal period and infant NAS care. Qualitative data that guided the tool's development will be presented, alongside findings from user testing and a pilot randomized trial.

View Event →
Feb
27
12:00 PM12:00
Opioid use disorders, CRAFT, Family, Buprenorphine

C-DIAS PSMG: Karen Osilla

It takes a village: Implementing a pragmatic trial to evaluate a group telehealth intervention for family members affected by opioid use disorder

Karen Osilla, PhD
Stanford University School of Medicine

ABSTRACT:
Opioid use disorder (OUD) has devastating effects on individuals, families, and communities. This presentation describes eINSPIRE (INtegrating Support Persons Into REcovery), a pragmatic randomized trial that tests the Community Reinforcement Approach and Family Training (CRAFT) intervention delivered via group telehealth therapy compared to usual care. CRAFT is an evidence-based approach for the family members or close friends (referred to as Support Persons; SPs) of individuals with a substance use disorder. Patients and SP dyads were recruited across five community health systems in Southern and Northern California that provide buprenorphine treatment and mental health services. This presentation will describe our dyadic recruitment and implementation insights on the adoption, reach, and feasibility of intervening with SPs in these settings.

View Event →